Skip to main content

Table 4 Post-operative treatments and recurrence rates in endometriale cancer: comparison between current study and literature data.

From: Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings

 

Stage

N patients

Treatment

Recurrence %

Pelvic or extrapelvic + pelvic recurrence

Mundt (22)

I-IV

43

Chemotherapy

67.4 %

49.3%

Smith (28)

IC-IV

39

CAP/RT

38.5%

20%

Gabriele(30)

III-IV

21

CAP/RT

57%

50%

Bruzzone

III-IV

45

CAP/RT

40%

77.8%

Martinez

I-III

132

HDWART

35%

59%

Greven

IC-III

46

Chemo/RT*

22%

30%

Current study

ICG3-III

23

Chemo/RT+

21.7%

None

  1. CAP/RT : Cisplatin, doxorubicin and cyclophosphamide followed by radiotherapy HDWART high-dose abdomino-pelvic irradiation ^ abdominal/pelvis and vagina recurrence
  2. Chemo/RT concomitant chemo-radiation *cisplatin days 1/28 followed after radiotherapy by cispaltin and paclitaxel
  3. +concomitant radiotherapy with paclitaxel
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us